Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy
Standard
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. / Alseraihy, Amal; McGrath, Eoin; Niederwieser, Dietger; Chabannon, Christian; Szer, Jeff; Mohty, Mohamad; Kharfan-Dabaja, Mohamed A; Orchard, Kim; Schwartz, Joseph; Rasheed, Walid; Koh, Mickey; Kröger, Nicolaus; Kodera, Yoshihisa; Fakih, Riad El; Worel, Nina; Manson, Lynn; Rintala, Tuula; Tabakhi, Abdelghani; Savani, Bipin; Gergis, Usama; Sureda, Anna; Eldridge, Paul W; Yakoub-Agha, Ibrahim; Hamadani, Mehdi; Weisdorf, Daniel; Greinix, Hildegard; Aljurf, Mahmoud.
In: TRANSPL CELL THER, Vol. 28, No. 8, 08.2022, p. 455-462.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy
AU - Alseraihy, Amal
AU - McGrath, Eoin
AU - Niederwieser, Dietger
AU - Chabannon, Christian
AU - Szer, Jeff
AU - Mohty, Mohamad
AU - Kharfan-Dabaja, Mohamed A
AU - Orchard, Kim
AU - Schwartz, Joseph
AU - Rasheed, Walid
AU - Koh, Mickey
AU - Kröger, Nicolaus
AU - Kodera, Yoshihisa
AU - Fakih, Riad El
AU - Worel, Nina
AU - Manson, Lynn
AU - Rintala, Tuula
AU - Tabakhi, Abdelghani
AU - Savani, Bipin
AU - Gergis, Usama
AU - Sureda, Anna
AU - Eldridge, Paul W
AU - Yakoub-Agha, Ibrahim
AU - Hamadani, Mehdi
AU - Weisdorf, Daniel
AU - Greinix, Hildegard
AU - Aljurf, Mahmoud
N1 - Copyright © 2022. Published by Elsevier Inc.
PY - 2022/8
Y1 - 2022/8
N2 - Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regulators, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the transplantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Network for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low- and middle-income economies.
AB - Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regulators, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the transplantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Network for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low- and middle-income economies.
KW - Accreditation
KW - Bone Marrow
KW - Cell- and Tissue-Based Therapy
KW - Health Facilities
KW - Hematopoietic Stem Cell Transplantation/methods
U2 - 10.1016/j.jtct.2022.04.003
DO - 10.1016/j.jtct.2022.04.003
M3 - SCORING: Review article
C2 - 35413459
VL - 28
SP - 455
EP - 462
JO - TRANSPL CELL THER
JF - TRANSPL CELL THER
SN - 2666-6375
IS - 8
ER -